Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

EuCARE

Financiado

European Cohorts of Patients and Schools to Advance Response to Epidemics

The EuCARE project gathers a comprehensive multidisciplinary team of clinicians, virologists, epidemiologists, statisticians and top experts in artificial intelligence to unveil the impact of SARS-CoV-2 variants on key sectors of... ver más

13/10/2026

EuResist

10M€

Presupuesto del proyecto: 10M€

Líder del proyecto

EURESIST NETWORK GEIE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 22 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2021-11-15

HORIZON-HLTH-2021-CORONA-01-02: Cohorts united against COVID-19 var... Expected Outcome:This topic aims at supporting activities that are enabling or contributing to the d...

I+D

Cerrada hace 3 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

22 Participantes

EuResist

2.72M€ | Lider

UNITOV

436.88K€ | Participante

UDUS

399.95K€ | Participante

UNISI

600.00K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

END-VOC ENDING COVID 19 VARIANTS OF CONCERN THROUGH COHORT STUDIES:... 10M€ Cerrado

CoVICIS EU-Africa Concerted Action on SAR-CoV-2 Virus Variant and Im... 10M€ Cerrado

PCI2020-120687-2 MULTI-SCALE ECO-EVOLUTION OF CORONAVIRUSES: FROM SURVEILLANC... 62K€ Cerrado

SOLVE Sustainable COVID-19 Vaccination for Long-term Vaccine Immun... 9M€ Cerrado

REMEDY The Effect of Resistance to Epidemic Measures on Disease Spr... 212K€ Cerrado

PID2021-127496NB-I00 ANALISIS DE LAS BASES MOLECULARES DE LA INTERACCION SARS-COV... 133K€ Cerrado

Duración del proyecto: 58 meses Fecha Inicio: 2021-11-15
Fecha Fin: 2026-10-13

Líder del proyecto

EURESIST NETWORK GEIE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 10M€

Descripción del proyecto The EuCARE project gathers a comprehensive multidisciplinary team of clinicians, virologists, epidemiologists, statisticians and top experts in artificial intelligence to unveil the impact of SARS-CoV-2 variants on key sectors of public health, as addressed by the call. The specific activities include: 1. The assessment of natural and artificial immunity to the different viral variants in health care workers with the aim of defining the cross-immunization patterns and the risk of vaccine escape, informing vaccination strategies for the general population; 2. The analysis of the clinical course and long-term follow-up of hospitalized COVID-19 patients to derive the role of different viral variants in the outcome of the infection, including post-acute sequelae of SARS-CoV-2 infection; 3. The definition of the best strategies to control the spread of different viral variants in schools, by comparing the outcome of diverse containment and prevention measures in relation to the prevalence and dynamics of the variants. To ensure a suitable representativeness of the different variants, vaccines and preventive measures, EuCARE has secured the appropriate cohorts from diverse geographic areas including European countries, Kenya, Mexico, Russia and Vietnam, and will consolidate or expand interactions with other cohorts. To deal with complex interactions among many variables, including large dimensional parameters, EuCARE harnesses the power of artificial intelligence to define the role of viral variants and inform clinical guidelines and prevention measures. In the longer-term, EuCARE is committed to maintain active cooperation beyond the duration of the project with a dedicated task in the project. The solid IT and ethics infrastructure and the harmonised research procedures will make the cohort and laboratory network rapidly available to tackle newly emerging infectious diseases, thus contributing to pandemic preparedness on a global scale.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores